0 Bedömningar

ID

37354

Beskrivning

Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form contains details on the administration of the investigational product and is to be filled in at Day 1, 2 and 3. Additionally, this form also contains Randomisation information and the assignment of the participant to one of the four cohorts for/prior to the first medication administration.

Länk

https://clinicaltrials.gov/ct2/show/NCT00996840

Nyckelord

  1. 2019-07-16 2019-07-16 -
  2. 2019-07-20 2019-07-20 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

20 juli 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :


    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    SB-681323 in ALI/ARDS risk patients - NCT00996840

    Investigational Product - IV Dosing, Randomisation, Cohort Assignment

    Administrative Data
    Beskrivning

    Administrative Data

    Alias
    UMLS CUI-1
    C1320722
    Subject ID
    Beskrivning

    Subject ID

    Datatyp

    integer

    Alias
    UMLS CUI [1]
    C2348585
    Date of Visit
    Beskrivning

    please fill in the form for each of the three study days

    Datatyp

    integer

    Alias
    UMLS CUI [1]
    C1320303
    Which Cohort is the subject enrolled in?
    Beskrivning

    Please ensure the Cohort selected is correct before submitting. Medication is infused over 4 or 24 hours depending on the cohort.

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C0599755
    Date/Time of Cohort Assignment
    Beskrivning

    Date/Time of Cohort Assignment

    Datatyp

    datetime

    Alias
    UMLS CUI [1,1]
    C0599755
    UMLS CUI [1,2]
    C1516050
    UMLS CUI [1,3]
    C1264639
    First Administration
    Beskrivning

    First Administration

    Alias
    UMLS CUI-1
    C3469597
    Dosage Duration (per Protocol)
    Beskrivning

    Cohorts 1/3: 0-4 hrs Cohorts 2/4: 0-24hrs

    Datatyp

    integer

    Alias
    UMLS CUI [1,1]
    C0449238
    UMLS CUI [1,2]
    C3469597
    UMLS CUI [1,3]
    C0304229
    Start Date and Time
    Beskrivning

    Start Date and Time

    Datatyp

    datetime

    Alias
    UMLS CUI [1]
    C3897500
    Stop Date and Time
    Beskrivning

    Stop Date and Time

    Datatyp

    datetime

    Alias
    UMLS CUI [1]
    C3899266
    Volume administered (mL)
    Beskrivning

    Volume administered

    Datatyp

    float

    Måttenheter
    • mL
    Alias
    UMLS CUI [1]
    C2349139
    mL
    Administration post interruption
    Beskrivning

    Administration post interruption

    Alias
    UMLS CUI-1
    C3469597
    UMLS CUI-2
    C0687676
    UMLS CUI-3
    C1512900
    Dosage Duration (per Protocol)
    Beskrivning

    Cohorts 1/3: 0-4 hrs Cohorts 2/4: 0-24 hrs

    Datatyp

    integer

    Alias
    UMLS CUI [1,1]
    C0449238
    UMLS CUI [1,2]
    C3469597
    UMLS CUI [1,3]
    C0304229
    Start Date and Time
    Beskrivning

    Start Date and Time

    Datatyp

    datetime

    Alias
    UMLS CUI [1]
    C3897500
    Stop Date and Time
    Beskrivning

    Stop Date and Time

    Datatyp

    datetime

    Alias
    UMLS CUI [1]
    C3899266
    Volume administered (mL)
    Beskrivning

    Volume administered

    Datatyp

    float

    Måttenheter
    • mL
    Alias
    UMLS CUI [1]
    C2349139
    mL
    Investigational Product Container Number
    Beskrivning

    Investigational Product Container Number

    Alias
    UMLS CUI-1
    C0304229
    UMLS CUI-2
    C0180098
    UMLS CUI-3
    C0600091
    Investigational Product Container Number
    Beskrivning

    Record the identifying number from the investigational product container dispensed at this visit

    Datatyp

    text

    Alias
    UMLS CUI [1,1]
    C0304229
    UMLS CUI [1,2]
    C0180098
    UMLS CUI [1,3]
    C0600091
    Treatment Confirmation
    Beskrivning

    Treatment Confirmation

    Alias
    UMLS CUI-1
    C0750484
    UMLS CUI-2
    C0087111
    Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
    Beskrivning

    If no, record reasons

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0087111
    UMLS CUI [1,2]
    C2349182
    Reason incorrect treatment
    Beskrivning

    if applicable

    Datatyp

    text

    Alias
    UMLS CUI [1,1]
    C0566251
    UMLS CUI [1,2]
    C0087111
    UMLS CUI [1,3]
    C3827420
    Randomisation Number
    Beskrivning

    Randomisation Number

    Alias
    UMLS CUI-1
    C0034656
    UMLS CUI-2
    C0237753
    Was the subject able to be randomised?
    Beskrivning

    If yes, provide Randomisation Number and Date/time of randomisation

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0034656
    UMLS CUI [1,2]
    C0332149
    Randomisation Number
    Beskrivning

    if applicable

    Datatyp

    integer

    Alias
    UMLS CUI [1,1]
    C0034656
    UMLS CUI [1,2]
    C0237753
    Date/time of randomisation
    Beskrivning

    if applicable

    Datatyp

    datetime

    Alias
    UMLS CUI [1,1]
    C0034656
    UMLS CUI [1,2]
    C1264639

    Similar models

    Investigational Product - IV Dosing, Randomisation, Cohort Assignment

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Administrative Data
    C1320722 (UMLS CUI-1)
    Subject ID
    Item
    Subject ID
    integer
    C2348585 (UMLS CUI [1])
    Item
    Date of Visit
    integer
    C1320303 (UMLS CUI [1])
    Code List
    Date of Visit
    CL Item
    Day 1 (1)
    CL Item
    Day 2 (2)
    CL Item
    Day 3 (3)
    Item
    Which Cohort is the subject enrolled in?
    text
    C0599755 (UMLS CUI [1])
    Code List
    Which Cohort is the subject enrolled in?
    CL Item
    Cohort 1 (3mg/Placebo IV / 4hrs) (C1)
    CL Item
    Cohort 2 (7.5mg/Placebo IV / 24hrs) (C2)
    CL Item
    Cohort 3 (7.5mg/Placebo IV / 4hrs) (C3)
    CL Item
    Cohort 4 (10mg/Placebo IV / 24hrs) (C4)
    Date/Time of Cohort Assignment
    Item
    Date/Time of Cohort Assignment
    datetime
    C0599755 (UMLS CUI [1,1])
    C1516050 (UMLS CUI [1,2])
    C1264639 (UMLS CUI [1,3])
    Item Group
    First Administration
    C3469597 (UMLS CUI-1)
    Item
    Dosage Duration (per Protocol)
    integer
    C0449238 (UMLS CUI [1,1])
    C3469597 (UMLS CUI [1,2])
    C0304229 (UMLS CUI [1,3])
    Code List
    Dosage Duration (per Protocol)
    CL Item
    0-4 hrs (1)
    CL Item
    0-24 hrs (2)
    Start Date and Time
    Item
    Start Date and Time
    datetime
    C3897500 (UMLS CUI [1])
    Stop Date and Time
    Item
    Stop Date and Time
    datetime
    C3899266 (UMLS CUI [1])
    Volume administered
    Item
    Volume administered (mL)
    float
    C2349139 (UMLS CUI [1])
    Item Group
    Administration post interruption
    C3469597 (UMLS CUI-1)
    C0687676 (UMLS CUI-2)
    C1512900 (UMLS CUI-3)
    Item
    Dosage Duration (per Protocol)
    integer
    C0449238 (UMLS CUI [1,1])
    C3469597 (UMLS CUI [1,2])
    C0304229 (UMLS CUI [1,3])
    Code List
    Dosage Duration (per Protocol)
    CL Item
    0-4 hrs (1)
    CL Item
    0-24 hrs (2)
    Start Date and Time
    Item
    Start Date and Time
    datetime
    C3897500 (UMLS CUI [1])
    Stop Date and Time
    Item
    Stop Date and Time
    datetime
    C3899266 (UMLS CUI [1])
    Volume administered
    Item
    Volume administered (mL)
    float
    C2349139 (UMLS CUI [1])
    Item Group
    Investigational Product Container Number
    C0304229 (UMLS CUI-1)
    C0180098 (UMLS CUI-2)
    C0600091 (UMLS CUI-3)
    Investigational Product Container Number
    Item
    Investigational Product Container Number
    text
    C0304229 (UMLS CUI [1,1])
    C0180098 (UMLS CUI [1,2])
    C0600091 (UMLS CUI [1,3])
    Item Group
    Treatment Confirmation
    C0750484 (UMLS CUI-1)
    C0087111 (UMLS CUI-2)
    Correct treatment received
    Item
    Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
    boolean
    C0087111 (UMLS CUI [1,1])
    C2349182 (UMLS CUI [1,2])
    Reason incorrect treatment
    Item
    Reason incorrect treatment
    text
    C0566251 (UMLS CUI [1,1])
    C0087111 (UMLS CUI [1,2])
    C3827420 (UMLS CUI [1,3])
    Item Group
    Randomisation Number
    C0034656 (UMLS CUI-1)
    C0237753 (UMLS CUI-2)
    Randomisation possible
    Item
    Was the subject able to be randomised?
    boolean
    C0034656 (UMLS CUI [1,1])
    C0332149 (UMLS CUI [1,2])
    Randomisation Number
    Item
    Randomisation Number
    integer
    C0034656 (UMLS CUI [1,1])
    C0237753 (UMLS CUI [1,2])
    Randomisation Date/Time
    Item
    Date/time of randomisation
    datetime
    C0034656 (UMLS CUI [1,1])
    C1264639 (UMLS CUI [1,2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial